Pricing Log in Create free account

Legend Biotech Corporation Sponsored ADR (LEGN) vs Tango Therapeutics, Inc. (TNGX)

Legend Biotech Corporation Sponsored ADR and Tango Therapeutics, Inc. are both Biotechnology companies. Legend Biotech Corporation Sponsored ADR and Tango Therapeutics, Inc. are of similar size ($3.8B and $3.8B). Legend Biotech Corporation Sponsored ADR grew revenue faster over the last twelve months: 59.6% against 48.3%. Tango Therapeutics, Inc. has the higher net margin (0.00% vs −7.20%) and the lower return on invested capital (−808.4% vs −9.54%). Across the 18 metrics below, Legend Biotech Corporation Sponsored ADR leads on 11 and Tango Therapeutics, Inc. on 7.

Valuation

Metric LEGN TNGX Biotechnology median
P/E n/m n/m 8.50
P/S 2.72 52.95 9.71
P/B 2.81 3.22 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.22 36.70 9.21
Earnings yield (2.68%) (3.81%) (33.15%)
Free cash flow yield (3.54%) (4.37%) (25.50%)

Profitability

Metric LEGN TNGX Biotechnology median
Gross margin 56.58% 100.00% 65.16%
Operating margin (5.06%) 0.00% 0.00%
Net margin (7.20%) 0.00% 0.00%
Free cash flow margin (9.58%) 0.00% 0.00%
Return on equity (8.08%) (21.34%) (56.36%)
Return on assets (5.32%) (18.86%) (48.04%)
Return on invested capital (9.54%) (808.35%) 0.00%

Growth

Metric LEGN TNGX Biotechnology median
Revenue growth (TTM) 59.55% 48.29% 6.02%
EPS growth (last fiscal year) (66.34%) 26.89% 30.26%
Revenue growth, 5-year CAGR 65.93% 52.13% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LEGN TNGX Biotechnology median
Debt to equity 0.13 0.00 0.00
Current ratio 3.04 50.82 4.72
Net debt to EBITDA 2.31 3.08 0.96

Dividend

Metric LEGN TNGX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LEGN TNGX Biotechnology median
Market cap 3.84b 3.83b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack